Abstract

Under microwave irradiation, eighteen new aroylhydrazone diorganotin complexes (1a–9b) were produced through the reaction of aroylhydrazine, 2-ketobutyric acid, and the corresponding diorganotin. Fourier transform infrared spectroscopy, 1H, 13C, and 119Sn nuclear magnetic resonance spectroscopies, high-resolution mass spectroscopy, X-ray crystallography, and thermogravimetric analysis (TGA) were performed to characterize the complexes. The in vitro anticancer activity for complexes were assessed using a CCK-8 assay on human cancer cells of HepG2, NCI-H460, and MCF-7. Complex 4b revealed more intensive anticancer activity against MCF-7 cells than the other complexes and cisplatin. Flow cytometry analysis and transmission electron microscope observation demonstrated that complex 4b mediated cell apoptosis of MCF-7 cells and arrested cell cycle in S phase. Western blotting analysis showed that 4b induced DNA damage in MCF-7 cells and led to apoptosis by the ATM-CHK2-p53 pathway. The single cell gel electrophoreses assay results showed that 4b induced DNA damage. The DNA binding activity of 4b was studied by UV–Visible absorption spectrometry, fluorescence competitive, viscosity measurements, gel electrophoresis, and molecular docking, and the results show that 4b can be well embedded in the groove and cleave DNA.

Highlights

  • During the last few years, it has been noticeable that organotin compounds occupy an important place in cancer chemotherapy reports [15–17] because of their cytotoxic effects, ability to bind with DNA, anti-proliferating nature, and apoptotic-inducing nature

  • Complexes 1a–9b were synthesized by the microwave-assisted method

  • As indicated by the data, 4b can mediate MCF-7 cancer cell apoptosis, which is consistent with the strong anticancer activity in 4b

Read more

Summary

Introduction

As standards of living have increased, the incidence and mortality of cancer have increased gradually. During the last few years, it has been noticeable that organotin compounds occupy an important place in cancer chemotherapy reports [15–17] because of their cytotoxic effects, ability to bind with DNA, anti-proliferating nature, and apoptotic-inducing nature. During the research and development of anticancer drugs, the growth inhibition experiment of drugs in vitro cancer cells is the first step in verifying the drug anticancer effects It is significant in clarifying drug anticancer spectrums and screening efficient anticancer drugs. Group studied the structure–activity relationships of new organotin (IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7, and HeLa human cancer cell lines [22]. Due to its good biological properties, and electron-donating atoms such as carbonyl oxygen and imino nitrogen, aroylhydrazone ligands have received extensive attention in the design of organotin anticancer drugs [23–26].

Synthesis
Spectroscopic Data Discussion
Crystal Structure
Anticancer Studies
Cell Apoptosis Analysis
Cell Cycle Distribution Analysis
TEM Observation of Cell Morphology
WesternAfter
Western blot analysis of complex4b
Comet Assay
Comet Assay the cells
2.10.1. UV–Visible Absorption Spectrometry
2.10. DNA-Binding Studies
2.10.3. Viscosity Measurements
2.10.5. Molecular
2.10.4. Gel Electrophoresis Studies
Methods
Diphenyltin-2-(2-benzoylhydrazono) Butyrate (1a)
Dibutyltin-2-(2-benzoylhydrazono) Butyrate (1b)
Diphenyltin-2-(2-(2-hydroxylbenzoyl)hydrazono)butyrate (2a)
Dibutyltin-2-(2-(2-hydroxylbenzoyl)hydrazono)butyrate (2b)
Diphenyltin-2-(2-(4-hydroxylbenzoyl)hydrazono)butyrate (3a)
Dibutyltin-2-(2-(4-hydroxylbenzoyl)hydrazono)butyrate (3b)
Diphenyltin-2-(2-(4-methylbenzoyl)hydrazono)butyrate (4a)
Dibutyltin-2-(2-(4-methylbenzoyl)hydrazono)butyrate (4b)
Diphenyltin-2-(2-(4-methoxybenzoyl)hydrazono)butyrate (5a)
3.2.10. Dibutyltin-2-(2-(4-methoxybenzoyl)hydrazono)butyrate (5b)
3.2.11. Diphenyltin-2-(2-(4-tert-butylbenzoyl)hydrazono)butyrate (6a)
3.2.12. Dibutyltin-2-(2-(4-tert-butylbenzoyl)hydrazono)butyrate (6b)
3.2.13. Diphenyltin-2-(2-(4-nitrobenzoyl)hydrazono)butyrate (7a)
3.2.14. Dibutyltin-2-(2-(4-nitrobenzoyl)hydrazono)butyrate (7b)
3.2.15. Diphenyltin-2-(2-furoylhydrazono)butyrate (8a)
3.2.16. Dibutyltin-2-(2-furoylhydrazono)butyrate (8b)
3.2.17. Diphenyltin-2-(2-thienoylhydrazono)butyrate (9a)
3.2.18. Dibutyltin-2-(2-thienoylhydrazono)butyrate (9b)
Single Crystal Structure Determination
In Vitro Anticancer Activity
Cell Apoptosis Assay
Cell Cycle Analysis
Transmission Electron Microscope (TEM)
Western Blot Analysis
3.10.1. UV–Visible Absorption Spectrometry
3.10.2. Fluorescence Competitive Study
3.10.3. Viscosity Measurements
3.10.4. Gel Electrophoresis Studies
3.10.5. Molecular Docking
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.